Table 3.
Serological Analysis of Variable Titers of IgA and IgG in Mice Challenged with H. Pylori and Treated with Shoya During 4 Months
| T3c(µg/ml) | T2b(µg/ml) | T1a(µg/ml) | Tested Mice | |||
|---|---|---|---|---|---|---|
| T3c | T2b | T1a | ||||
| IgG | IgA | IgG | IgA | IgG | IgA | |
| 4±0.23 | 5±0.27 | 21±0.88 | 30±0.12 | 3±1.23 | 6 ±1.34 | 1 |
| 2±1.21 | 3±1.61 | 18±0.97 | 27±0.39 | 2±1.11 | 5 ± 1.29 | 2 |
| 2±2.13 | 8±1.81 | 7±2.11 | 35±0.99 | 3±0.78 | 7.5 ±1.2 | 3 |
| 2±1.33 | 4±2.20 | 7±1.21 | 15±1.11 | 4±0.93 | 8 ± 1.02 | 4 |
| 2±0.87 | 3±1.23 | 8±1.29 | 12±1.21 | 2±1.24 | 3.5 ±1.48 | 5 |
| 2±1.12 | 3±2.48 | 7±2.11 | 13±1.43 | 2.5±1.78 | 4 ± 1.11 | 6 |
| 2±0.89 | 3.5±1.11 | 6±0.22 | 17±1.65 | 3±2.13 | 5± 1.42 | 7 |
| 3±0.79 | 9±7.40 | 15±1.15 | 45±0.34 | 4±2.53 | 9 ± 1.63 | 8 |
| 3±1.26 | 4±2.01 | 15±1.10 | 19±0.84 | 5±2.36 | 6.5 ±.12 | 9 |
| 2.5±2.01 | 3.5±1.22 | 16±1.17 | 23.5±0.38 | 6±0.79 | 7 ± 1.43 | 10 |
| 3±0.96 | 4±2.43 | 16±2.11 | 28.5±1.41 | 5±0.63 | 9 ± 2.18 | 11 |
| 3±1.24 | 3±0.75 | 17±1.19 | 29±1.32 | 3±2.16 | 4 ± 1.21 | 12 |
| 3.5± 1.09 | 4±1.88 | 11±1.32 | 12±1.65 | 2.5±2.32 | ± 2.423 | 13 |
| 2.5±2.11 | 4±1.37 | 12±0.86 | 14±1.67 | 2±.94 | 3.5 ±0.89 | 14 |
| 2.5±1.31 | 3±2.17 | 12±1.53 | 17±2.22 | 2±1.37 | 3 ±0.96 | 15 |
T1a:
Titers of specific anti-H. pylori IgA and IgG in tested mice sera before challenging with H. pylori
T2b;
Titers of specific anti-H. pylori IgA and IgG in mice sera two weeks after challenging with H. pylori.
T3c;
final titers of IgA and IgG in mice infected with H. pylori and treated two weeks with Shoya suspension. Antibody levels are shown as Mean ± SD of ODR per microgram of protein units for anti H.pylori IgG and IgA.